Testing the Psychometric Properties of the Habits of Health Scale for Children and Youth

This paper describes the validity testing we performed on one-half of the Habits of Health and Habits of Mind© model to increase research on the daily habits of children and youth and to substantiate the teaching and dissemination of the model with greater confidence. Child and adolescent health habits were tested with a new Habits of Health Scale (HHS). The study purpose was to test the construct and criterion validity of the habits of health measurement subscales which included physical activity, nutrition, relationships, safety, and hygiene behaviors. Two specific hypotheses were tested. The first hypothesis was that the HHS items would show acceptable factorial validity. The second hypothesis was the HHS factors would demonstrate high criterion validity, or the sensitivity of the scale to detect differences and associations that theoretically should exist. The HHS factors were expected to differ based on participants’ gender, perceived health status, perceived academic success, Body Mass Index (BMI), and multiple health behaviors. Results showed that each subscale demonstrated acceptable internal consistency and criterion validity. Health patterns and routines of kids can now be measured by the Habits of Health Scale, which is a multi-behavioral assessment tool that assesses the health status of children and youth.

Download Full-text

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

Journal of Patient-Reported Outcomes ◽

10.1186/s41687-019-0161-y ◽

2019 ◽

Vol 3 (1) ◽

Author(s):

A. Barnadas ◽

◽

M. Muñoz ◽

M. Margelí ◽

J. I. Chacón ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Health Status ◽

Bone Metastasis ◽

Assessment Tool ◽

Metastatic Breast ◽

Perceived Health ◽

Perceived Health Status ◽

Patient Reported

Abstract Background Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life (HRQoL). We tested prospectively the psychometric properties of the Bone Metastasis Quality of Life (BOMET-QoL-10) measure on MBC patients with BM. Methods Patients completed the BOMET-QoL-10 questionnaire, the Visual Analogue Scale (VAS) for pain, and a self-perceived health status item at baseline and at follow-up visits. We performed psychometric tests and calculated the effect size of specific BM treatment on patients´ HRQoL. Results Almost 70% of the 172 patients reported symptoms, 23.3% experienced irruptive pain, and over half were receiving chemotherapy. BOMET-QoL-10 proved to be a quick assessment tool performing well in readability and completion time (about 10 min) with 0–1.2% of missing/invalid data. Although BOMET-QoL-10 scores remained fairly stable during study visits, differences were observed for patient subgroups (e.g., with or without skeletal-related events or adverse effects). Scores were significantly correlated with physician-reported patient status, patient-reported pain, symptoms, and perceived health status. BOMET-QoL-10 scores also varied prospectively according to changes in pain intensity. Conclusions BOMET-QoL-10 performed well as a brief, easy-to-administer, useful, and sensitive HRQoL measure for potential use for clinical practice with MBC patients. Trial registration NCT03847220. Retrospectively registered on clinicaltrials.gov (February the 20th 2019).

Download Full-text